Übersetzung für "Interventional trial" in Deutsch

The NIS is an observational study with the main objective of capturing detailed clinical data on the bleeding episodes and haemophilia medication use of patients with haemophilia A outside of an interventional trial setting.

If an interventional trial is proposed on the basis of a feasibility study funded under this programme, the submission of a draft proposal is not required.

The trials will enable researchers to address current, urgent questions in patient-oriented clinical research within the framework of a controlled interventional trial.

Medical Biometry deals primarily with interventional clinical trials.

Also, she already performed nutritional intervention trials in adolescents.

This was also found in a recent intervention trial (Carlson et al, 2013).

Low-intervention clinical trials are mainly conducted by academia, and are essential for the advancement and progression of medical practice.

The funding duration of interventional trials and observational trials is initially 36 months.

These recommendations are based on a substantial body of scientific evidence, including large randomized intervention trials.

For intervention trials with omega-3 fatty acids, participants used to be recruited irrespective of their baseline omega-3 fatty acids.

The effects of alendronate on bone mass and fracture incidence in post-menopausal women were examined in two initial efficacy studies of identical design (n=994) as well as in the Fracture Intervention Trial (FIT: n=6,459).

The MAH also submitted data from four interventional clinical trials and six observational studies, which investigated the safety and efficacy of Kogenate Bayer/Helixate NexGen in haemophilia A patients, including studies 200021EU and 100074US in PUPs and minimally treated patients (MTPs).

The Outcome Reduction with Initial Glargine Intervention trial (i.e., ORIGIN) was an open-label, randomised, 12,537 patient study that compared LANTUS to standard care on the time to first occurrence of a major adverse cardiovascular event (MACE).

Where, upon receipt of the additional explanations, the remaining time period for notifying the decision referred to in paragraph 4 is less than three days in the case of low-intervention clinical trials, and less than five days for other than low-intervention clinical trials, it shall be extended to three and five days respectively.

Where, upon receipt of the additional explanations, the remaining time period for submitting Part I of the assessment report is less than three days in the case of low-intervention clinical trials, and less than five days for other than low-intervention clinical trials, it shall be extended to three and five days respectively.

Those low-intervention clinical trials are often of crucial importance for assessing standard treatments and diagnoses, thereby optimising the use of medicinal products and thus contributing to a high level of public health.

Those categories are compatible with the categories of clinical trials defined in this Regulation as the OECD Categories A and B(1) correspond to the definition of a low-intervention clinical trial as set out in this Regulation, and the OECD Categories B(2) and C correspond to the definition of a clinical trial as set out in this Regulation.